retatrutide side effects phase 2 trial 2026 Retatrutide as a Novel Treatment

One non-randomized open-label study, published over 2 separate articles, showed that 4-week liraglutide led to an improvement in a test of executive functioning (and possibly other cognitive measures) 178 and related increase in fronto-striatal volumes 179 , partly moderated by BMI and insulin resistance changes, in 19 people diagnosed with bipolar disorder or major depression

Tirzepatide favors GIPR over GLP-1R activity and it is biased for cAMP over -arrestin recruitment at GLP-1R (7476)

This synergy helps GLP-1 patients achieve a healthier body composition by focusing on fat loss while maintaining or even gaining muscle mass

doi: 10.1002/bies.202400016

2.5 Ethical considerations Ethical approval was not required for this review, as it did not involve the collection of primary data

Science 336 , 1262 (2012)